companydata.dkLEO PHARMA A/S: Financial statements 2018
CVR: 56759514
LEO PHARMA A/S (CVR 56759514) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 10,410,000,000 and a net result of DKK 1,258,000,000 compared with DKK 1,381,000,000 the year before. That is a decrease of 0.7% compared with the year before. The profit margin was 12.1%. Equity amounted to DKK 9,528,000,000. The solvency ratio was 58.5%.
- Revenue
- 10,410,000,000 kr.
- Gross Profit
- 7,370,000,000 kr.
- Profit/Loss
- 1,258,000,000 kr.
- Equity
- 9,528,000,000 kr.
- Total Assets
- 16,284,000,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 10.4 mia. | 7.4 mia. | 1.3 mia. | 9.5 mia. | - |
| 2017 | 10.5 mia. | 7.5 mia. | 1.4 mia. | 8.3 mia. | - |
| 2016 | 7.4 mia. | 2.7 mia. | 743 mio. | 25.2 mia. | 5170 |
| 2015 | 6.9 mia. | 2 mia. | 645 mio. | 25.3 mia. | 4813 |
| 2014 | 6.6 mia. | - | 1.5 mia. | 24.5 mia. | 4712 |
Keep an eye on LEO PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of August 27, 2018, Patrik Olof Dahlén has joined the board of directors of LEO PHARMA A/S.
As of August 27, 2018, Olivier Bohuon has joined the board of directors of LEO PHARMA A/S.
As of August 26, 2018, Patrik Olof Dahlén has left the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2017. Revenue came to DKK 10,481,000,000, and the net result was DKK 1,381,000,000.
As of February 27, 2018, Signe Maria Christensen has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Henrik Bo Andersson has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Jesper Mailind has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Franck Maréno has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Fie Falck Bruus Madsen has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Sammy Islam Al-Moalem has joined the board of directors of LEO PHARMA A/S.
About LEO PHARMA A/S
LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Philip Harald Eickhoff and Christophe Dominique Luc Charles Bourdon. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 2,040 employees. In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity amounted to DKK 5,262,000,000.